$18 Million ALS Research Grant for Stem Cell Therapy Applauded by ALS Advocates

On July 26th 2012, the governing board of California's Stem Cell Agency approved an $18 million Disease Team research grant that aims to bring a stem cell-based ALS treatment to clinical trials. The project team is led by Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute and chair of the California ALS Research Network. For more info about CIRM-funded ALS research, see our fact sheet

© 2013 California Institute for Regenerative Medicine